EDAP TMS S.A. (ADR) (NASDAQ:EDAP)

CAPS Rating: No stars

The Company and its subsidiaries are engaged in the development, production, marketing, distribution and maintenance of a portfolio of minimally-invasive medical devices for the treatment of urological diseases.

Results 1 - 4 of 4

Recs

0
Member Avatar benyboy (< 20) Submitted: 4/27/2012 5:40:13 AM : Outperform Start Price: $2.06 EDAP Score: -6.59

The Street

Recs

0
Member Avatar Downeastah (39.90) Submitted: 6/19/2011 5:02:32 PM : Outperform Start Price: $3.07 EDAP Score: -45.70

A SAFER APPROACH TO A CANCER PROBLEM THAT HAS BEEN AROUND FOR YEARS AND THAT HAS BEEN TREATED WITH NUMEROUS, OLDER METHODS. AND NOW WE HAVE EDAP'S PROVEN TECHNOLOGY.

Recs

0
Member Avatar hoperalot1 (< 20) Submitted: 12/17/2010 3:27:43 PM : Outperform Start Price: $2.16 EDAP Score: -44.78

Get it while you can!!. Edap has product and procedure to reach 20+

Recs

0
Member Avatar geo11zak (< 20) Submitted: 12/16/2010 8:14:47 AM : Outperform Start Price: $4.89 EDAP Score: -69.57

valuation, great product ,

Results 1 - 4 of 4

Featured Broker Partners


Advertisement